Profile | GDS5420 / 1555812_a_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 868.61 | 77 |
GSM1296119 | B_lesional_pre-dose | 2545.42 | 92 |
GSM1296076 | C_lesional_pre-dose | 2038.73 | 88 |
GSM1296092 | D_lesional_pre-dose | 1804.11 | 87 |
GSM1296103 | E_lesional_pre-dose | 1475.89 | 85 |
GSM1296078 | F_lesional_pre-dose | 1924.22 | 88 |
GSM1296107 | G_lesional_pre-dose | 1740.6 | 87 |
GSM1296109 | H_lesional_pre-dose | 1329.79 | 84 |
GSM1296080 | I_lesional_pre-dose | 401.06 | 64 |
GSM1296090 | J_lesional_pre-dose | 2123.2 | 89 |
GSM1296074 | K_lesional_pre-dose | 2270.76 | 89 |
GSM1296111 | L_lesional_pre-dose | 2205.71 | 90 |
GSM1296099 | M_lesional_pre-dose | 1677.29 | 87 |
GSM1296086 | O_lesional_pre-dose | 1843.57 | 87 |
GSM1296117 | P_lesional_pre-dose | 2063.48 | 90 |
GSM1296113 | Q_lesional_pre-dose | 1736.44 | 88 |
GSM1296096 | R_lesional_pre-dose | 2036.96 | 89 |
GSM1296105 | S_lesional_pre-dose | 1221.5 | 82 |
GSM1296098 | T_lesional_pre-dose | 814.82 | 76 |
GSM1296101 | U_lesional_pre-dose | 1454.78 | 85 |
GSM1296121 | V_lesional_pre-dose | 2254.09 | 90 |
GSM1296088 | W_lesional_pre-dose | 1232.44 | 82 |
GSM1296082 | X_lesional_pre-dose | 2203.29 | 89 |
GSM1296115 | Y_lesional_pre-dose | 1783.32 | 88 |
GSM1296084 | Z_lesional_pre-dose | 1171.5 | 81 |
GSM1296072 | B_lesional_day8 | 1813.39 | 88 |
GSM1296069 | L_lesional_day8 | 2529.76 | 93 |
GSM1296071 | P_lesional_day8 | 1948.74 | 90 |
GSM1296070 | Y_lesional_day8 | 1657.93 | 87 |
GSM1296073 | V_lesional_day8 | 2461.13 | 91 |
GSM1296034 | A_lesional_day15 | 453.59 | 65 |
GSM1296041 | G_lesional_day15 | 1699.6 | 87 |
GSM1296035 | R_lesional_day15 | 2294.66 | 91 |
GSM1296038 | U_lesional_day15 | 1674.01 | 87 |
GSM1296047 | B_lesional_day15 | 1813.12 | 88 |
GSM1296039 | E_lesional_day15 | 2796.26 | 92 |
GSM1296042 | H_lesional_day15 | 1878.94 | 89 |
GSM1296043 | L_lesional_day15 | 1965.86 | 90 |
GSM1296037 | M_lesional_day15 | 1252.14 | 83 |
GSM1296046 | P_lesional_day15 | 1751.37 | 88 |
GSM1296044 | Q_lesional_day15 | 1713.13 | 88 |
GSM1296045 | Y_lesional_day15 | 1886.63 | 89 |
GSM1296025 | C_lesional_day15 | 547.09 | 69 |
GSM1296033 | D_lesional_day15 | 969.23 | 78 |
GSM1296027 | I_lesional_day15 | 524.76 | 69 |
GSM1296032 | J_lesional_day15 | 883.35 | 77 |
GSM1296024 | K_lesional_day15 | 703.8 | 73 |
GSM1296031 | W_lesional_day15 | 1500.18 | 86 |
GSM1296028 | X_lesional_day15 | 948.99 | 78 |
GSM1296029 | Z_lesional_day15 | 1326.81 | 83 |
GSM1296026 | F_lesional_day15 | 1050.35 | 80 |
GSM1296030 | O_lesional_day15 | 921.1 | 77 |
GSM1296040 | S_lesional_day15 | 1225.66 | 82 |
GSM1296036 | T_lesional_day15 | 873.75 | 77 |
GSM1296048 | V_lesional_day15 | 2505.41 | 92 |
GSM1296059 | A_lesional_day43 | 1472.09 | 85 |
GSM1296066 | G_lesional_day43 | 1422.46 | 85 |
GSM1296060 | R_lesional_day43 | 2130.04 | 90 |
GSM1296063 | U_lesional_day43 | 2033.33 | 89 |
GSM1296064 | E_lesional_day43 | 2509.78 | 91 |
GSM1296067 | H_lesional_day43 | 1952.83 | 90 |
GSM1296062 | M_lesional_day43 | 791.07 | 75 |
GSM1296068 | Q_lesional_day43 | 1580.44 | 87 |
GSM1296050 | C_lesional_day43 | 1493.56 | 85 |
GSM1296057 | D_lesional_day43 | 1783 | 88 |
GSM1296052 | I_lesional_day43 | 678.21 | 73 |
GSM1296054 | J_lesional_day43 | 684.44 | 73 |
GSM1296049 | K_lesional_day43 | 858.32 | 77 |
GSM1296055 | W_lesional_day43 | 2007.02 | 90 |
GSM1296053 | X_lesional_day43 | 569.46 | 69 |
GSM1296058 | Z_lesional_day43 | 1645.49 | 86 |
GSM1296051 | F_lesional_day43 | 2142.92 | 89 |
GSM1296056 | O_lesional_day43 | 2869.71 | 92 |
GSM1296065 | S_lesional_day43 | 2051.31 | 90 |
GSM1296061 | T_lesional_day43 | 765.62 | 74 |
GSM1296095 | A_non-lesional_pre-dose | 1992.72 | 89 |
GSM1296120 | B_non-lesional_pre-dose | 1999.04 | 89 |
GSM1296077 | C_non-lesional_pre-dose | 772.24 | 75 |
GSM1296093 | D_non-lesional_pre-dose | 540.91 | 68 |
GSM1296104 | E_non-lesional_pre-dose | 2232.81 | 90 |
GSM1296079 | F_non-lesional_pre-dose | 1014.39 | 79 |
GSM1296108 | G_non-lesional_pre-dose | 1624.97 | 87 |
GSM1296110 | H_non-lesional_pre-dose | 1489.52 | 86 |
GSM1296081 | I_non-lesional_pre-dose | 486.25 | 67 |
GSM1296091 | J_non-lesional_pre-dose | 1068.17 | 80 |
GSM1296075 | K_non-lesional_pre-dose | 1750.47 | 87 |
GSM1296112 | L_non-lesional_pre-dose | 1649.62 | 88 |
GSM1296100 | M_non-lesional_pre-dose | 1032.15 | 80 |
GSM1296087 | O_non-lesional_pre-dose | 603.58 | 71 |
GSM1296118 | P_non-lesional_pre-dose | 1266.2 | 83 |
GSM1296114 | Q_non-lesional_pre-dose | 1474.42 | 86 |
GSM1296097 | R_non-lesional_pre-dose | 1710.79 | 87 |
GSM1296106 | S_non-lesional_pre-dose | 1733.81 | 88 |
GSM1296102 | U_non-lesional_pre-dose | 1245.97 | 83 |
GSM1296122 | V_non-lesional_pre-dose | 1557.64 | 86 |
GSM1296089 | W_non-lesional_pre-dose | 1263.2 | 83 |
GSM1296083 | X_non-lesional_pre-dose | 636.03 | 71 |
GSM1296116 | Y_non-lesional_pre-dose | 1373.53 | 85 |
GSM1296085 | Z_non-lesional_pre-dose | 766.42 | 75 |